E
Eugenio Caturelli
Researcher at Casa Sollievo della Sofferenza
Publications - 159
Citations - 7078
Eugenio Caturelli is an academic researcher from Casa Sollievo della Sofferenza. The author has contributed to research in topics: Hepatocellular carcinoma & Biopsy. The author has an hindex of 41, co-authored 153 publications receiving 6087 citations. Previous affiliations of Eugenio Caturelli include Catholic University of the Sacred Heart.
Papers
More filters
Journal ArticleDOI
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
Giuseppe Manghisi,Silvana Elba,Ascanio Mossa,Antonio Giorgio,V Aloisio,A. Perrotta,Berardino Tardio,Carlo Del Naja,Eugenio Caturelli,Maria Calandra,L. Castellano,Ilario de Sio,Gaetano Capuano,Domenico Pomponi,Fabiana Castiglione,Pasqualina Cocchia,Fabio Farinati,M. Rinaldi,Luigi Elio Adinolfi,Enrico Ragone,Martina Felder,Laura Zancanella,Giuseppe Pasquale,Maria Stanzione,Giampiero Marone,Valentina D’Angelo,Giovanni Battista Gaeta,Giancarlo Giolitto,Bruno Lamborgese,Luigi Manzione,Michele Russo,Raffaele Colurcio,Enzo Veltri,Francesco Izzo,Gabriele Budillon,Nicola Caporaso,Camillo Del Vecchio Blanco,B. Galanti,Giuseppe Giusti,Gabriele Mazzacca,Silvio Monfardini,Felice Piccinino,Giuseppe Ruggiero,Ciro Gallo,Francesco Perrone,Sabino De Placido,Giuliana Canzanella,Bruno Daniele,Sandro Pignata +48 more
TL;DR: The aims of this study were to verify the value of known prognostic factors and to devise a prognostic index more sensitive than the commonly used Okuda stage, and to produce a new prognostic system that accounts for both liver function and tumor characteristics.
Journal ArticleDOI
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
V. Santi,Franco Trevisani,Annagiulia Gramenzi,Alice Grignaschi,Federica Mirici-Cappa,Paolo Poggio,Maria Anna Di Nolfo,Luisa Benvegnù,Fabio Farinati,Marco Zoli,Edoardo G. Giannini,Franco Borzio,Eugenio Caturelli,Maria Chiaramonte,Mauro Bernardi +14 more
TL;DR: Semiannual surveillance increases the detection rate of very early hepatocellular carcinomas and reduces the number of advanced tumors as compared to the annual program, which translates into a greater applicability of effective treatments and into a better prognosis.
Journal ArticleDOI
Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.
Maurizio Pompili,Antonio Saviano,Nicoletta De Matthaeis,Alessandro Cucchetti,Francesco Ardito,Bruno Federico,Franco Brunello,Antonio D Pinna,Antonio Giorgio,Stefano Maria Giulini,Ilario de Sio,Guido Torzilli,Fabio Fornari,Lorenzo Capussotti,Alfredo Guglielmi,Fabio Piscaglia,Luca Aldrighetti,Eugenio Caturelli,Fulvio Calise,Gennaro Nuzzo,Gian Ludovico Rapaccini,Felice Giuliante +21 more
TL;DR: In spite of a higher rate of local tumor progression, radiofrequency ablation can provide results comparable to liver resection in the treatment of single hepatocellular carcinoma ≤3 cm occurring in compensated cirrhosis.
Journal ArticleDOI
Prognosis of untreated hepatocellular carcinoma
Edoardo G. Giannini,Fabio Farinati,Francesca Ciccarese,A. Pecorelli,Gian Lodovico Rapaccini,Mariella Di Marco,Luisa Benvegnù,Eugenio Caturelli,Marco Zoli,Franco Borzio,Maria Chiaramonte,Franco Trevisani +11 more
TL;DR: In untreated patients with advanced HCC, female gender, clinical decompensation of cirrhosis, and multinodular tumor are independent prognostic predictors and should be taken into account for patient stratification in future therapeutic studies.
Journal ArticleDOI
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study
Alessandro Vitale,Patrizia Burra,Anna Chiara Frigo,Franco Trevisani,Fabio Farinati,Gaya Spolverato,Michael L. Volk,Edoardo G. Giannini,Francesca Ciccarese,Fabio Piscaglia,Gian Lodovico Rapaccini,Mariella Di Marco,Eugenio Caturelli,Marco Zoli,Franco Borzio,Giuseppe Cabibbo,Martina Felder,Antonio Gasbarrini,Rodolfo Sacco,Francesco Giuseppe Foschi,Gabriele Missale,Filomena Morisco,Gianluca Svegliati Baroni,Roberto Virdone,Umberto Cillo +24 more
TL;DR: Resection could result in survival benefit over LRT for HCC patients regardless of their BCLC stage, provided that liver dysfunction (Child B or MELD>9) and PST>1 are absent.